CBE News and Events

The uncertainty of how the COVID-19 virus will continue to impact education and the shift to online classes and remote research has raised many questions, especially for our graduate students. We have put together a list of frequently asked questions in the hopes to ease some of your concerns.
The uncertainty of how the COVID-19 virus will continue to impact education and the shift to online classes has raised many questions, especially for our undergraduate students. We have put together a list of frequently asked questions in the hopes to ease some of your concerns.
Dear students, As the CBE Department prepares for remote course instruction, we ask that you download several programs and applications to ease the transition from an in-class to an online format.

TROY, N.Y. — The lives of people with Type 1 diabetes could be significantly enhanced through algorithms that connect glucose monitors and insulin pumps to automatically regulate blood glucose to healthy levels, in the same fashion that cruise control in an automobile regulates speed.

SABIC has an opening for a chemical engineering who is early in their career. A BS in Chemical Engineering with 3 years of experience is required.

Institute News

TROY, N.Y. — With COVID-19 still spreading in the United States, where it has already killed more than 140,000 people, improved screening and treatment options are critically important for high-risk patients with comorbidities, such as diabetes, pulmonary disease, and cardiovascular disease.

TROY, N.Y. —When the Shewanella oneidensis bacterium “breathes” in certain metal and sulfur compounds anaerobically, the way an aerobic organism would process oxygen, it produces materials that could be used to enhance electronics, electrochemical energy storage, and drug-delivery devices.

In a test of antiviral effectiveness against the virus that causes COVID-19, an extract from edible seaweeds substantially outperformed remdesivir, the current standard antiviral used to combat the disease.

TROY, N.Y. — With hurricane season already underway and projected to be active, communities throughout the U.S. are trying to balance disaster preparation amid an unprecedented public health crisis. While significant attention is rightly being given to COVID-19, leaders – especially those in communities along the coast – must plan for the possibility of dual disasters.

A common drug, already approved by the Food and Drug Administration (FDA), may also be a powerful tool in fighting COVID-19, according to research published this week in Antiviral Research.